Trials / Sponsors / Rexahn Pharmaceuticals, Inc.
Rexahn Pharmaceuticals, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer Metastatic Renal Cell Cancer | Phase 1 / Phase 2 | 2014-08-01 |
| Terminated | RX-5902 Treatment of Subjects With Triple Negative Breast Cancer Solid Tumor, Triple Negative Breast Cancer | Phase 1 / Phase 2 | 2013-08-01 |
| Completed | Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder Major Depressive Disorder | Phase 2 | 2010-12-01 |
| Completed | A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic Cancer Metastatic Pancreatic Cancer | Phase 2 | 2009-05-01 |
| Completed | Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD) Major Depressive Disorder (MDD) | Phase 2 | 2009-01-01 |
| Completed | Efficacy Study of RX-10100 to Treat Erectile Dysfunction (ED) Erectile Dysfunction (ED) | Phase 2 | 2008-06-01 |